Background: Thalassemia is the most common single gene disease in human beings. The prevalence rate of b-thalassemia in Taiwan is approximately 1-3%. Previously methods to reveal and diagnose severe deleted form of a-or b-thalassemia were insufficient and inappropriate for prenatal diagnosis. Methods: A real-time quantitative PCR method was set up for rapid screening of the deleted form of b-thalassemia. Results: Our results show that DDCt between deleted form of b-thalassemia and normal individuals were 1.0674 AE 0.0713. On the contrary, mutation form b-thalassemia showed no difference with normal healthy control. The HBB/CCR5 ratio for deleted form of b-thalassemia patients was 0.48, whether normal individuals and mutation form of b-thalassemia was 1.0. Conclusion: This RQ-PCR technique is an alternative rapid screening assay for deleted form of b-thalassemia. In addition, it could also identify undefined type. Our technique by using RQ-PCR to quantify gene copies is a reliable and time-saving method that can screen deleted form of b-thalassemia.
INTRODUCTION
Thalassemia is the most common single gene disease in human beings. The decrease or absence of b-globin production leads to b-thalassemia (1, 2). The b-globin gene cluster is composed of five genes in the arrangement of 5'-e-c G -c A -d-b-3' and is located at minus strand of chromosome 11 (3) . The whole length of gene cluster spans around 60 kb. More than 250 mutations in b-globin gene have been reported to cause b-thalassemia, and most of them are point mutations (4) (5) (6) . Until now, more than 20 b-globin gene mutated or deleted forms have been found in Taiwanese population (7) . The prevalence rate of b-thalassemia in Taiwan is 1-3% approximately (7, 8) . Four common types of the point mutations, namely HBB:c.-78A>G (promoter À28 A?G), c.52A>T (codon 17 AAG? TAG), c.125_128delTCTT (codon 41-42-TCTT) and c.316-197C>T (IVS-2 nt 654 C?T) mutations, were the main cause of b-thalassemia in more than 80% of patients in Taiwan (9) . However, 3-5% cases belong to deleted form of b-thalassemia, including U01317.1:g.37242_116449del79208 (Southeast Asian type of hereditary persistence of hemoglobin F; HPFH-SEA), U01317.1:g.40454_119300del78847 (Chinese Gc + (Acdb)°type), and Yunnanese type (10) (11) (12) (13) (14) . To diagnose those deleted forms of b-thalassemia, duplex PCR was used to amplify the junction in clinical laboratories (13) (14) (15) . According to Globin Gene Server (http://globin.cse.psu.edu/), there are 17 different large-fragment b-globin deleted forms that have been reported but not able to be identified by current duplex PCR in clinical laboratories (16) .
Previous studies showed that cDNA/DNA hybridization techniques were used to discover severe deleted form of a-or b-thalassemia (17) (18) (19) . However, those techniques are not only inappropriate for prenatal diagnosis but also laborious in a clinical laboratory. Therefore, we try to set up a real-time quantitative PCR (RQ-PCR) method for rapid screening of the deleted form of b-thalassemia.
DESIGN AND METHODS

Patients and Controls
From 2002 to 2007, a total of 112 patients from Kaohsiung Medical University Hospital were enrolled for this study. Out of the 112 patients, eight patients were detected as b-globin heterozygous deletions, 34 patients as mutated b-thalassemia and 70 healthy persons served as normal controls. Genomic DNA was extracted using a NucleoSpin Ò genomic DNA from blood kit according to the manufacturer's instructions (Macherey-Nagel GmbH & Co., D€ uren, Germany).
Detection of b-thalassemia by PCR-RFLP and Duplex PCR
To detect point mutated b-thalassemia, PCR-restriction fragment length polymorphism (PCR-RFLP) method was used as described in our previous report (9) . To detect HPFH-SEA, a duplex PCR was used with three primers bridging the 3' breakpoint (13). The upstream primer 5'-TGGTATCTGCAGCAGTTGCC-3' (NT 5207166 to 5207147 in NC_000011) and the downstream primer 5'-AGCCTCATGGTAGCA-GAATC-3' (NT 5179380 to 5179399 in NC_000011) were used to amplify the breakpoint region. For normal control, another upstream primer 5'-ATTGTT-GAGTTGCAAGATCG-3' (NT 5179944 to 5179925 in NC_000011) with the downstream primer around the breakpoint region were used. To detect Yunnanese deletion (Acdb)°, a upstream primer 5'-TTCCCCA-CACTATCTCAATGC-3' (NT 5227764 to 5227744 in NC_000011) and a downstream primer 5'-CAAGGC-CAGGGAGAACTGC-3' (NT 5207049 to 5207068 in NC_000011 of GenBank) were used to amplify breakpoint region. Identical upstream primer with downstream primer 5'-AGAGGACAGGTTGCCAAAGC-3' (NT 5227336 to 5227355 in NC_000011) was used to amplify the normal 5' area around the breakpoint region (14) . To detect Chinese deletion (Gc + (Acdb)°), cA1 5'-GCTGGACACATATAAAATGCTGC-3' (NT 5226740 to 5226718 in NC_000011) and cA3 5'-AGAAATTGCCTCATGTCTCT-3' (NT 5147639 to 5147658 in NC_000011) were used to amplify the breakpoint region. cA2 5'-TGCAGG-TAGTTGTTCCCCTTCA-3' (NT 5226443 to 5226464 in NC_000011) and cA1 were used to amplify normal 5' sequence around the breakpoint region (12) . Approximately 0.2~1.0 lg genomic DNA was mixed with 50 ng of each primer and 200 lM of each dNTP in 50 ll reaction buffer containing 10 mM Tris-HCl (pH 8.3) 50 mM KCl, 1.5 mM MgCl 2 , and 2.5 units of Taq polymerase. PCR amplification was carried out in an ABI 9700 thermal cycler. The mixture was incubated at 95°C for 5 min, followed by thirty-six amplification cycles of 95°C for 1 min denaturation, 52°C for 1 min annealing and 72°C for 2 min extension. The amplified PCR product was further incubated at 72°C for 7 min to ensure the complete extension. The PCR products were analyzed by electrophoresis on 2% agarose gel and visualized in UV light.
PCR Primers for Real-Time Quantitative PCR (RQ-PCR)
Primers for RQ-PCR were designed by a DNASTAR PrimerSelect. The primers for HBB gene were HBB145F 5'-TGGTATCAAGGTTACAAGACAGGT TT-3' (NT 5204733 to 5204708 in NC_000011) and HBB245R 5'-CAGAGAGAGTCAGTGCCTATCAG AA-3' (NT 5204633 to 5204654 in NC_000011). The internal control primers for CCR5 gene were CCR5F 5'-GAACCTTGACGGCATTGC-3' (NT 46391197 to 46391214 in plus strand of NC_000003) and CCR5R 5'-CCTCCCTCCTTCCCATCC-3' (NT: 46391394 to 46391377 in plus strand of NC_000003).
Real-Time Quantitative PCR
The RQ-PCR combined with the dissociation curve analysis was used to determine HBB gene copy number of patients. CCR5 gene served as a reference to normalize and enable the comparability of RQ-PCR data. Delta Ct value (cycle threshold value; DCt) was calculated by subtracting Ct (HBB) from Ct (CCR5) . Delta Ct was calculated by subtracting DCt (b-thalassemia group) from DCt (normal healthy control). RQ-PCRs were performed on a LightCycler 1.0 or LightCycler 480 (Roche Diagnostics; F. Hoffmann-La Roche Ltd., Basel, Switzerland). Each reaction was carried out in 2 ll of 100 ng/ll genomic DNA and 8 ll reaction mixture containing 2.4 mM MgCl 2 , 1 U of FastStart DNA Master Mix SYBR Green I (containing Taq DNA polymerase, SYBR Green I, and deoxynucleoside triphosphate mix), 0.6 lM of the primers (forward and reverse). PCRs were subjected to 10 min of 95°C hot-start enzyme activation, and 40 cycles of 95°C denaturation for 5 sec, 64°C annealing for 5 sec, 72°C elongation for 12 sec, and 80°C signal detection for 0 sec. To avoid cross-contamination and sample carryover, pre-and post-PCR sample processing were performed in separate rooms. All fluid transfers were carried out with plugged pipette tips to eliminate aerosols. Diethyl pyrocarbonate (DEPC)-treated water served as the template for negative control amplifications, which were included with each PCR run. Amplified DNA products were detected by melting curve analysis which consisted of 95°C for 5 sec, 65°C for 30 sec, and continuously heated at the rate of 0.1°C/sec until 95°C. For analysis of the melting curves, the Light Cycler instrument's software that automatically converts them into melting peaks was used. The T m 's of the peaks were analyzed using the best-fit analysis software provided by Roche Diagnostics (F. Hoffmann-La Roche Ltd.).
Statistical Analysis
Results were analyzed by SPSS version 11.5 for Windows (SPSS Inc., Chicago, IL). One-way ANOVA and Scheffe post hoc analysis were used to test continuous variables in three different groups. A P value <0.05 was considered statistically significant.
RESULTS AND DISCUSSION
All of the b-thalassemia forms were diagnosed by the PCR-RFLP and duplex PCR methods. Figure 1 shows the duplex PCR result of a case of Gc + (Acdb)°of Chinese type. For RQ-PCR screening, the PCR efficiency of these two primer pairs was of no difference. HBB145F and HBB245R primer pair was used for detection of target HBB gene, whereas CCR5F and CCR5R primer pair for CCR5 gene severed as a reference control. In this study, genomic DNA from normal populations were serial diluted and quantified by RQ-PCR using HBB145F and HBB245R, and CCR5F and CCR5R primer pairs to test their PCR efficiency. The amplification curve was shown in the Figure 2a . According to the cycle number vs. concentration for each standard, standard curve for target HBB gene were constructed (figures were not shown). The average slope of HBB145F and HBB245R primer pair was 3.738 AE 0.18 and the average PCR efficiency was 1.852 AE 0.02. However, the average slope of CCR5F and CCR5R primer pair was 3.707 AE 0.15 and the average PCR efficiency was 1.872 AE 0.02. The melting point of PCR product of HBB gene was 82.76°C, whereas product of CCR5 gene was 88.06°C (Fig. 2b) . No other non-specific product was found in melting curve analysis and electrophoresis.
The copy numbers of HBB gene in deleted form of b-thalassemia were significantly different from normal individuals (P < 0.001). The mean DDCt in each run of Q-PCR was 0.0035 AE 0.1765 in normal individuals, 0.0558 AE 0.2209 in mutational form of b-thalassemia, and 1.0709 AE 0.1759 in deleted form of b-thalassemia. One-way ANOVA and Scheffe post hoc were used to test the difference of DDCt among the three groups (Fig. 3) . The result showed F = 113.189 and P < 0.001 in one-way ANOVA. The mean difference of DDCt was 1.0674 AE 0.0713 between deleted form of b-thalassemia and normal individuals, and 1.0151 AE 0.0751 between deleted form and mutation form of b-thalassemia. The HBB/CCR5 ratio for deleted form of b-thalassemia patients was 0.48, whereas for normal individuals and mutation form of b-thalassemia, it was 1.0.
This RQ-PCR technique is an alternative rapid screening assay for deleted form of b-thalassemia and could be used to find out undefined type. The cDNA/ DNA hybridization technique is used to discover severe deletion forms of a and b-thalassemia (18) . In this method, the initial step is the isolation of messenger RNA and translation by incubating with wheat germ cell-free system containing [
14 C]-leucine. Then, cDNA is hybridized to mRNA, b-enriched cDNA, and total DNA to determine whether mismatched hybrids of low stability are formed at the lower temperature. It takes a long time for each step. In 1979, Orkin et al. (16) used restriction endonuclease mapping of cell DNA to investigate the deleted form of b-thalassemia. The diagnostic procedure started from using EcoRI, used breakpoint junction PCR/gel electrophoresis method to detect Indian HPFH G c A c(db) 0 -thalassemia. In 1990, field-inversion gel electrophoresis was used to detect Belgian Gc + (Acdb) 0 -thalassemia (21) . Fluorescent in situ hybridization with b-globin genes as probe to detect the b-globin gene copy is also a reliable method (22) . However, this method is time consuming and need relative more viable cells. Currently, duplex PCR with three primers bridging the 3' breakpoint is a widely used method as it can only detect each of wellknown deleted forms (12) (13) (14) . A real-time PCR LightCycler technology using fluorescence and melting curve analysis has been developed in 1998 (23) . Since then the nucleic acid-based diagnostics were widely used in clinical practice for the detection of microorganisms (24) , gene polymorphisms (25) , lymphoma (26, 27) , and many other diseases (28, 29) .
In conclusion, the deleted b-thalassemia, including HPFH-SEA, Chinese Gc + (Acdb)°type and Yunnanese type, can be screened through the change in DDCt and it could also identify undefined type of deleted b-thalassemia. Our technique, RQ-PCR, to quantify gene copies is a reliable and time-saving method that can screen deleted forms of b-thalassemia.
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